Hospital Vall d'Hebron-ko ikertzaileekin lankidetzan egindako argitalpenak (14)

2021

  1. Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)

    Scientific Reports

2019

  1. Archeogenetics of F11 p.Cys38Arg: A 5400-year-old mutation identified in different southwestern European countries

    Blood

2018

  1. The prognostic impact of additional intrathoracic findings in patients with cancer-related pulmonary embolism

    Clinical and Translational Oncology, Vol. 20, Núm. 2, pp. 230-242

2017

  1. Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: The EPIPHANY study

    European Respiratory Journal, Vol. 49, Núm. 1

  2. Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: The EPIPHANY Index

    British Journal of Cancer, Vol. 116, Núm. 8, pp. 994-1001

  3. Prognostic value of computed tomography pulmonary angiography indices in patients with cancer-related pulmonary embolism: Data from a multicenter cohort study

    European Journal of Radiology, Vol. 87, pp. 66-75

2016

  1. On the necessity of new decision-making methods for cancer-associated, symptomatic, pulmonary embolism

    Thrombosis Research, Vol. 143, pp. 76-85

2015

  1. Coste por paciente con respuesta a romiplostim y rituximab en el tratamiento de la trombocitopenia inmune primaria en España

    Medicina Clinica, Vol. 144, Núm. 9, pp. 389-396

  2. Embolia pulmonar en el paciente oncológico: bases para el estudio EPIPHANY

    Medicina Clinica, Vol. 144, Núm. S1, pp. 31-37

2014

  1. Proteomic analysis of platelet N-glycoproteins in PMM2-CDG patients

    Thrombosis Research, Vol. 133, Núm. 3, pp. 412-417

2013

  1. GPI-anchor and GPI-anchored protein expression in PMM2-CDG patients

    Orphanet Journal of Rare Diseases, Vol. 8, Núm. 1

2012

  1. Diagnóstico, tratamiento y seguimiento de la trombocitopenia inmune primaria

    Medicina Clinica

2010

  1. Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocythemia

    Blood, Vol. 116, Núm. 8, pp. 1205-1210

2007

  1. The association of the β1-tubulin Q43P polymorphism with intracerebral hemorrhage in men

    Haematologica, Vol. 92, Núm. 4, pp. 513-518